These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29983670)

  • 1. CD44 glycoprotein in cancer: a molecular conundrum hampering clinical applications.
    Azevedo R; Gaiteiro C; Peixoto A; Relvas-Santos M; Lima L; Santos LL; Ferreira JA
    Clin Proteomics; 2018; 15():22. PubMed ID: 29983670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion.
    Gaiteiro C; Soares J; Relvas-Santos M; Peixoto A; Ferreira D; Paulo P; Brandão A; Fernandes E; Azevedo R; Palmeira C; Freitas R; Miranda A; Osório H; Prieto J; Lima L; Silva AMN; Santos LL; Ferreira JA
    Theranostics; 2022; 12(7):3150-3177. PubMed ID: 35547758
    [No Abstract]   [Full Text] [Related]  

  • 3. CD44: structure, function, and association with the malignant process.
    Naor D; Sionov RV; Ish-Shalom D
    Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon.
    Jackson DG; Bell JI; Dickinson R; Timans J; Shields J; Whittle N
    J Cell Biol; 1995 Feb; 128(4):673-85. PubMed ID: 7532175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression.
    Bourguignon LY; Zhu D; Zhu H
    Front Biosci; 1998 Jul; 3():d637-49. PubMed ID: 9634539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural variability of CD44v molecules and reliability of immunodetection of CD44 isoforms using mAbs specific for CD44 variant exon products.
    Martegani MP; Del Prete F; Gasbarri A; Natali PG; Bartolazzi A
    Am J Pathol; 1999 Jan; 154(1):291-300. PubMed ID: 9916943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into Bioinformatic Applications for Glycosylation: Instigating an Awakening towards Applying Glycoinformatic Resources for Cancer Diagnosis and Therapy.
    Muthu M; Chun S; Gopal J; Anthonydhason V; Haga SW; Jacintha Prameela Devadoss A; Oh JW
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico approaches for unveiling novel glycobiomarkers in cancer.
    Azevedo R; Silva AMN; Reis CA; Santos LL; Ferreira JA
    J Proteomics; 2018 Jan; 171():95-106. PubMed ID: 28782717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of CD44 variant 6 expression and clinicopathological factors in pulmonary metastases from colon carcinoma.
    Indinnimeo M; Cicchini C; Giarnieri E; Stazi A; Mingazzini PL; Stipa V
    Oncol Rep; 2003; 10(6):1875-7. PubMed ID: 14534711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions.
    Bajorath J
    Proteins; 2000 May; 39(2):103-11. PubMed ID: 10737932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 and the adhesion of neoplastic cells.
    Rudzki Z; Jothy S
    Mol Pathol; 1997 Apr; 50(2):57-71. PubMed ID: 9231152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells.
    Galluzzo E; Albi N; Fiorucci S; Merigiola C; Ruggeri L; Tosti A; Grossi CE; Velardi A
    Eur J Immunol; 1995 Oct; 25(10):2932-9. PubMed ID: 7589094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel variants of CD44 arising from alternative splicing: changes in the CD44 alternative splicing pattern of MCF-7 breast carcinoma cells treated with hyaluronidase.
    Tanabe KK; Nishi T; Saya H
    Mol Carcinog; 1993; 7(4):212-20. PubMed ID: 8352881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons.
    Bennett KL; Modrell B; Greenfield B; Bartolazzi A; Stamenkovic I; Peach R; Jackson DG; Spring F; Aruffo A
    J Cell Biol; 1995 Dec; 131(6 Pt 1):1623-33. PubMed ID: 8522617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-linked glycosylation modifies CD44 adhesion to hyaluronate in colon carcinoma cells.
    Dasgupta A; Takahashi K; Cutler M; Tanabe KK
    Biochem Biophys Res Commun; 1996 Oct; 227(1):110-7. PubMed ID: 8858111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44s adhesive function spontaneous and PMA-inducible CD44 cleavage are regulated at post-translational level in cells of melanocytic lineage.
    Gasbarri A; Del Prete F; Girnita L; Martegani MP; Natali PG; Bartolazzi A
    Melanoma Res; 2003 Aug; 13(4):325-37. PubMed ID: 12883358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular studies into the role of CD44 variants in metastasis in gastric cancer.
    Hsieh HF; Yu JC; Ho LI; Chiu SC; Harn HJ
    Mol Pathol; 1999 Feb; 52(1):25-8. PubMed ID: 10439835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD44 variants in lung cancer and its relationship to hyaluronan binding.
    Matsubara Y; Katoh S; Taniguchii H; Oka M; Kadota J; Kohno S
    J Int Med Res; 2000; 28(2):78-90. PubMed ID: 10898120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.